Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role (Q37887977)

24 August 2017

1 reference

title

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role (English)

1 reference

24 August 2017

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

4 December 2024

1 reference

0 references

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

B. Fromenty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21664213

4 December 2024

J. Aubert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21664213

4 December 2024

K. Begriche

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21664213

4 December 2024

L. Knockaert

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21664213

4 December 2024

M. A. Robin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21664213

4 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21664213

4 December 2024

publication date

12 June 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S2210740111001732?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

https://api.elsevier.com/content/article/PII:S2210740111001732?httpAccept=text/plain

4 December 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Clinics and research in hepatology and gastroenterology

4 December 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

630-637

1 reference

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

The role of the lipogenic pathway in the development of hepatic steatosis.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mechanisms of acetaminophen-induced liver necrosis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N terminus and requires mitochondrial specific electron transfer proteins for activity

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

The 2006 Bernard B. Brodie Award Lecture. Cyp2e1.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

High-fat emulsion-induced rat model of nonalcoholic steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Role of alcohol metabolism in non-alcoholic steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

4 December 2024

The double life of Irs.

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Basal α-Cell Up-Regulation in Obese Insulin-Resistant Adolescents

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Adipokines in liver diseases

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Effects of a high-fat diet on energy metabolism and ROS production in rat liver

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Halothane hepatitis in Iran: a review of 59 cases

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Binge ethanol exposure increases liver injury in obese rats

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Influence of high body mass index on outcome in acute liver failure

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

An overfed rat model that reproduces acetaminophen disposition in obese humans

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Prevalence of and risk factors for hepatic steatosis in Northern Italy

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

[Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Targeting mitochondria: a new promising approach for the treatment of liver diseases.

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation

4 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINRE.2011.04.015

4 December 2024

Identifiers

1 reference

24 August 2017

1 reference